← Leaderboards
Julie A. Johnson
University Of Florida
$37,866,281
Attributed
$52,215,969
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$72,951,912 · 10
By mechanism
U01$47,792,465 · 3
UM1$16,593,003 · 1
R01$6,140,571 · 3
T32$1,682,405 · 1
K24$598,780 · 1
R03$144,688 · 1
Top collaborators
- Larisa Humma Cavallari7 shared
- Thomas A Pearson5 shared
- Oscar R Benavente3 shared
- Cynthia A Gerhardt3 shared
- Alan R. Shuldiner3 shared
- Rhonda M Cooper-Dehoff2 shared
- Stephen E. Kimmel2 shared
Most similar at University Of Florida
Same institution · by research overlap
- Rhonda M Cooper-Dehoff$672,170
- Julie E. Johnson$637,515
- Elvin Tyrone Price$43,336
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponsePharmacogeneticsPharmaceutical PreparationsGenetic PolymorphismGenotypeBaseHypertensionGenomic MedicineFundingBlood PressureFloridaClinical ResearchPharmacotherapyGenetic DeterminismGeneticGenomicsPharmacogenomicsProgramsLeadHealth SystemPhenotypeClinical PracticePatient CareAmerican
Grant awards (64)
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health$5,459,563
UM1 · FY2025 · TR · contact PI
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health$5,510,458
UM1 · FY2024 · TR · contact PI
IGNITE EP2 - Admin Supplement$258,184
U01 · FY2024 · HG
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health$5,622,982
UM1 · FY2023 · TR · contact PI
IGNITE Cost Extension - Admin Supplement$1,351,790
U01 · FY2023 · HG
Sparking Advancements in Genomic Medicine$1,290,318
U01 · FY2022 · HG
Sparking Advancements in Genomic Medicine$750,442
U01 · FY2022 · HG
Sparking Advancements in Genomic Medicine$623,311
U01 · FY2022 · HG · contact PI
Training Program for Applied Research and Development in Genomic Medicine$359,635
T32 · FY2022 · HG · contact PI
Sparking Advancements in Genomic Medicine$925,611
U01 · FY2021 · HG · contact PI
Training Program for Applied Research and Development in Genomic Medicine$348,918
T32 · FY2021 · HG · contact PI
Sparking Advancements in Genomic Medicine$2,518,062
U01 · FY2020 · HG · contact PI
Training Program for Applied Research and Development in Genomic Medicine$339,224
T32 · FY2020 · HG · contact PI
Training Program for Applied Research and Development in Genomic Medicine$79,772
T32 · FY2020 · HG · contact PI
Sparking Advancements in Genomic Medicine$2,344,174
U01 · FY2019 · HG · contact PI
Sparking Advancements in Genomic Medicine$367,409
U01 · FY2019 · HG · contact PI
Training Program for Applied Research and Development in Genomic Medicine$316,916
T32 · FY2019 · HG · contact PI
Sparking Advancements in Genomic Medicine$77,000
U01 · FY2019 · HG · contact PI
Sparking Advancements in Genomic Medicine$922,335
U01 · FY2018 · HG · contact PI
Training Program for Applied Research and Development in Genomic Medicine$161,266
T32 · FY2018 · HG · contact PI
Training Program for Applied Research and Development in Genomic Medicine$76,674
T32 · FY2018 · HG · contact PI
Genomic Medicine Implementation: The Personalized Medicine Program$930,567
U01 · FY2017 · HG · contact PI
Genomic Medicine Implementation: The Personalized Medicine Program$1,034,134
U01 · FY2016 · HG · contact PI
Genomic Medicine Implementation: The Personalized Medicine Program$576,249
U01 · FY2016 · HG · contact PI
Genomic Medicine Implementation: The Personalized Medicine Program$962,192
U01 · FY2015 · HG · contact PI
Genomic Medicine Implementation: The Personalized Medicine Program$59,175
U01 · FY2015 · HG · contact PI
Pharmacogenomic Evaluation of Antihypertensive Responses$1,975,100
U01 · FY2014 · GM · contact PI
Parent Project$1,975,100
U01 · FY2014 · GM · contact PI
Genomic Medicine Implementation: The Personalized Medicine Program$978,729
U01 · FY2014 · HG · contact PI
Genomic Medicine Implementation: The Personalized Medicine Program$242,218
U01 · FY2014 · HG · contact PI
Parent Project$1,978,380
U01 · FY2013 · GM · contact PI
Pharmacogenomic Evaluation of Antihypertensive Responses$1,900,848
U01 · FY2013 · GM · contact PI
Genomic Medicine Implementation: The Personalized Medicine Program$749,835
U01 · FY2013 · HG · contact PI
Secondary Prevention of Subcortical Stroke Prevention Genetic Substudy$612,577
R01 · FY2013 · NS · contact PI
Parent Project$1,932,019
U01 · FY2012 · GM · contact PI
Pharmacogenomic Evaluation of Antihypertensive Responses$1,932,019
U01 · FY2012 · GM · contact PI
Secondary Prevention of Subcortical Stroke Prevention Genetic Substudy$671,934
R01 · FY2012 · NS · contact PI
Pharmacogenomic Evaluation of Antihypertensive Responses$1,976,439
U01 · FY2011 · GM · contact PI
Parent Project$1,976,439
U01 · FY2011 · GM · contact PI
Secondary Prevention of Subcortical Stroke Prevention Genetic Substudy$745,177
R01 · FY2011 · NS · contact PI
Parent Project$2,232,849
U01 · FY2010 · GM · contact PI
Pharmacogenomic Evaluation of Antihypertensive Responses$2,064,000
U01 · FY2010 · GM · contact PI
Pharmacogenomic Evaluation of Antihypertensive Responses$168,849
U01 · FY2010 · GM · contact PI
Pharmacogenomic Evaluation of Antihypertensive Responses$2,346,440
U01 · FY2009 · GM · contact PI
Pharmacogenomic Evaluation of Antihypertensive Responses$149,635
U01 · FY2009 · GM · contact PI
Pharmacogenomic Evaluation of Antihypertensive Responses$2,344,064
U01 · FY2008 · GM · contact PI
Pharmacogenomic Evaluation of Antihypertensive Responses$2,396,496
U01 · FY2007 · GM · contact PI
Pharmacogenomic Evaluation of Antihypertensive Responses$1,867,074
U01 · FY2006 · GM · contact PI
Hypertension Pharmacogenetics$804,308
R01 · FY2006 · HL · contact PI
Beta-receptors and cardiovascular pharmacogenomics$125,319
K24 · FY2006 · HL · contact PI
Pharmacogenomic Evaluation of Antihypertensive Responses$1,614,979
U01 · FY2005 · GM
Hypertension Pharmacogenetics$835,849
R01 · FY2005 · HL
Beta-receptors and cardiovascular pharmacogenomics$122,455
K24 · FY2005 · HL
Hypertension Pharmacogenetics$855,574
R01 · FY2004 · HL
Beta-receptors and cardiovascular pharmacogenomics$119,675
K24 · FY2004 · HL
Hypertension Pharmacogenetics$892,652
R01 · FY2003 · HL
BETA-ADRENERGIC RECEPTOR POLYMORPHISMS AND HYPERTENSION$180,625
R01 · FY2003 · HL
Beta-receptors and cardiovascular pharmacogenomics$116,976
K24 · FY2003 · HL
BETA-ADRENERGIC RECEPTOR POLYMORPHISMS AND HYPERTENSION$180,625
R01 · FY2002 · HL
Beta-receptors and cardiovascular pharmacogenomics$114,355
K24 · FY2002 · HL
Beta-adrenoceptor genetic polymorphisms and obesity$72,438
R03 · FY2002 · HL
BETA-ADRENERGIC RECEPTOR POLYMORPHISMS AND HYPERTENSION$180,625
R01 · FY2001 · HL
Beta-adrenoceptor genetic polymorphisms and obesity$72,250
R03 · FY2001 · HL
BETA-ADRENERGIC RECEPTOR POLYMORPHISMS AND HYPERTENSION$180,625
R01 · FY2000 · HL